By Greg Mannix, VP, EMEA Business Development, LSN
When we think of a partnering conference like Redefining Ever Stage of Investment (RESI), we often envision cutting-edge life science startups pitching their technologies to investors and licensing partners – whether through one-on-one meetings or in the Innovator’s Pitch Challenge (IPC). While this is certainly a key aspect of the event, it’s important to note that about 20% of the scheduled and ad hoc meetings at RESI are between investors themselves!
So, why is RESI such a prime venue for investors from around the world? Because cross-border alliances and syndicates are not just common – they’re becoming essential. Consider these key trends:
- Syndicates are the new normal: Single-investor participation in funding rounds is now rare. More often, deals are made through syndicates, which help spread risk and allow investors to tap into broader networks and expertise.
- Expanding geographic horizons: Investors who restrict their focus to just one region may struggle to compete for the most innovative technologies. As a result, many are looking beyond their comfort zones to find the best opportunities.
- The global capital gap: European companies often find it difficult to secure the capital needed for larger rounds within Europe, creating a growing need to partner with US and Asian investors.
On March 30th, right before RESI Europe in Barcelona, LSN will host an exclusive Investor-only Networking Event, bringing together investors from North America, Europe, and Asia for an evening of tapas, drinks, and new connections. For more information, contact resi@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment